Submission Details
| 510(k) Number | K024062 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 09, 2002 |
| Decision Date | March 03, 2003 |
| Days to Decision | 84 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K024062 is an FDA 510(k) clearance for the ASCENSIA BREEZE BLOOD GLUCOSE METER, a Glucose Oxidase, Glucose (Class II — Special Controls, product code CGA), submitted by Bayer Corp. (Elkhart, US). The FDA issued a Cleared decision on March 3, 2003, 84 days after receiving the submission on December 9, 2002. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1345.
| 510(k) Number | K024062 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 09, 2002 |
| Decision Date | March 03, 2003 |
| Days to Decision | 84 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | CGA — Glucose Oxidase, Glucose |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1345 |